首页> 外文期刊>BMC Cancer >Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection
【24h】

Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection

机译:根治性肝切除术后术前EpCAM循环肿瘤细胞和外周Treg细胞水平与肝细胞癌早期复发的关系

获取原文
           

摘要

Background This study was carried out to determine the prognostic significance of preoperative peripheral epithelial cell adhesion molecule- positive ( EpCAM +) circulating tumor cell (CTC) and T regulatory (Treg) cell levels in hepatocellular carcinoma (HCC) patients for the prediction of postoperative recurrence following curative resection. Methods A total of 49 patients about to undergo curative resection for HCC were recruited into the study. PCR and FACS were used to detect the preoperative levels of EpCAM mRNA+ CTCs and CD4+CD25+Foxp3+ Treg cells. The prognostic value of EpCAM mRNA+ CTCs, CD4+CD25+Foxp3+ Treg cells, and other clinicopathological factors were analyzed by applying the Kaplan–Meier method and the multivariate Cox proportional hazards model. Results The number of EpCAM mRNA+ CTCs and Treg/CD4+ cells showed significant correlation as prognostic factors of postoperative HCC recurrence: EpCAM mRNA+ CTC?≥?2.22 (P?=?0.001) and Treg/CD4+?≥?5.07 ( P =?0.045), with EpCAM mRNA+ CTC?≥?2.22 ( P =?0.003, HR?=?6.668) being the most important indicator. Patients with high CTC/Treg levels showed a significantly higher risk of developing postoperative HCC recurrence than those with low CTC/Treg levels (66.7?% vs. 10.3?%, P Conclusions Elevated EpCAM mRNA+ CTC and Treg/CD4+ levels were associated with early recurrence of HCC, indicative of poor clinical outcome. The combined detection of EpCAM mRNA+ CTC and Treg/CD4+ may therefore provide a novel prognostic predictor for HCC patients.
机译:背景本研究旨在确定术前外周血上皮细胞粘附分子阳性(EpCAM + )循环肿瘤细胞(CTC)和T调节(Treg)细胞水平在肝细胞癌(HCC)中的预后意义)用于预测根治性切除术后术后复发的患者。方法共有49例即将接受肝癌根治性切除术的患者入选本研究。 PCR和FACS检测EpCAM mRNA + CTCs和CD4 + CD25 + Foxp3 + Treg的水平细胞。 EpCAM mRNA + CTCs,CD4 + CD25 + Foxp3 + Treg细胞的预后价值及其他临床病理因素应用Kaplan-Meier方法和多元Cox比例风险模型进行分析。结果EpCAM mRNA + CTC的数量与Treg / CD4 + 细胞的数量与术后HCC复发的预后因素呈显着相关性:EpCAM mRNA + CTC?≥ ≥2.22(P <= 0.001)和Treg / CD4 + ≥≥5.07(P =≥0.045),而EpCAM mRNA + CTC≥≥2.22(P = 0.003,HR = 6.668)是最重要的指标。 CTC / Treg水平高的患者与低CTC / Treg水平的患者相比,术后HCC复发的风险显着更高(66.7%vs. 10.3%,P)结论EpCAM mRNA + CTC和Treg升高/ CD4 + 水平与HCC的早期复发相关,表明临床预后较差; EpCAM mRNA + CTC和Treg / CD4 +

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号